115 related articles for article (PubMed ID: 32818862)
1. Oncogenic transformation of human benign prostate hyperplasia with chronic cadmium exposure.
Prajapati A; Chauhan G; Shah H; Gupta S
J Trace Elem Med Biol; 2020 Dec; 62():126633. PubMed ID: 32818862
[TBL] [Abstract][Full Text] [Related]
2. CD147, MMP-1, MMP-2 and MMP-9 protein expression as significant prognostic factors in human prostate cancer.
Zhong WD; Han ZD; He HC; Bi XC; Dai QS; Zhu G; Ye YK; Liang YX; Qin WJ; Zhang Z; Zeng GH; Chen ZN
Oncology; 2008; 75(3-4):230-6. PubMed ID: 18852494
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of Low density lipoprotein Receptor-related Protein 1 (LRP-1) and matrix metalloproteinase-9 (MMP-9) in prostate gland: From normal to malignant lesions.
Gilardoni MB; Remedi MM; Oviedo M; Dellavedova T; Sarría JP; Racca L; Dominguez M; Pellizas CG; Donadio AC
Pathol Res Pract; 2017 Jan; 213(1):66-71. PubMed ID: 27931798
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples.
Gravina GL; Mancini A; Ranieri G; Di Pasquale B; Marampon F; Di Clemente L; Ricevuto E; Festuccia C
Int J Oncol; 2013 Jun; 42(6):2116-22. PubMed ID: 23589051
[TBL] [Abstract][Full Text] [Related]
5. Klf4 transcription factor is expressed in the cytoplasm of prostate cancer cells.
Le Magnen C; Bubendorf L; Ruiz C; Zlobec I; Bachmann A; Heberer M; Spagnoli GC; Wyler S; Mengus C
Eur J Cancer; 2013 Mar; 49(4):955-63. PubMed ID: 23089465
[TBL] [Abstract][Full Text] [Related]
6. [Expression and clinical significance of transcription factors in prostate cancer].
Ge L; Shan Z; Han Q; Hu J; Liu H; Guan Q; Qu X; Chen K
Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(10):755-8. PubMed ID: 24844959
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical studies of the expression of matrix metalloproteinase-2 and metalloproteinase-9 in human prostate cancer.
Zeng H; Xiao Y; Lu G; Chen Y
J Huazhong Univ Sci Technolog Med Sci; 2003; 23(4):373-4, 379. PubMed ID: 15015639
[TBL] [Abstract][Full Text] [Related]
8. [Expressions of the androgen receptor in normal prostate, benign prostatic hyperplasia and prostate cancer].
Zeng R; Liu ZY; Sun YH; Xu CL; Gao X; Jiao L
Zhonghua Nan Ke Xue; 2010 Nov; 16(11):967-72. PubMed ID: 21218636
[TBL] [Abstract][Full Text] [Related]
9. Zinc and cadmium analysis in human prostate neoplasms.
Bryś M; Nawrocka AD; Miekoś E; Zydek C; Foksiński M; Barecki A; Krajewska WM
Biol Trace Elem Res; 1997; 59(1-3):145-52. PubMed ID: 9522056
[TBL] [Abstract][Full Text] [Related]
10. Impairment of IGF2 gene expression in prostate cancer is triggered by epigenetic dysregulation of IGF2-DMR0 and its interaction with KLF4.
Schagdarsurengin U; Lammert A; Schunk N; Sheridan D; Gattenloehner S; Steger K; Wagenlehner F; Dansranjavin T
Cell Commun Signal; 2017 Oct; 15(1):40. PubMed ID: 29017567
[TBL] [Abstract][Full Text] [Related]
11. Prolactin- and testosterone-induced carboxypeptidase-D correlates with increased nitrotyrosines and Ki67 in prostate cancer.
Thomas LN; Merrimen J; Bell DG; Rendon R; Too CK
Prostate; 2015 Nov; 75(15):1726-36. PubMed ID: 26202060
[TBL] [Abstract][Full Text] [Related]
12. Underexpression of MMP-2 and its regulators, TIMP2, MT1-MMP and IL-8, is associated with prostate cancer.
Reis ST; Antunes AA; Pontes-Junior J; Sousa-Canavez JM; Dall'Oglio MF; Piantino CB; Cruz JA; Morais DR; Srougi M; Leite KR
Int Braz J Urol; 2012; 38(2):167-74. PubMed ID: 22555040
[TBL] [Abstract][Full Text] [Related]
13. [Expressions of endothelin-1 in benign prostatic hyperplasia and prostate cancer and their significance].
Zhou WQ; Sun YH; Yin HL; Zhang ZY; Ge JP; Cheng W; Ma HQ; Wei W; Zhou SG; Ma HH; Gao JP
Zhonghua Nan Ke Xue; 2007 Aug; 13(8):685-9. PubMed ID: 17918704
[TBL] [Abstract][Full Text] [Related]
14. [Expressions of E-cadherin and alpha-catenin in benign, malignant and metastatic prostate tumors].
Jiang T; Jiang H; Su XM; Zheng L; Li QL; Zhang ZW; Li XC
Zhonghua Nan Ke Xue; 2012 Jun; 18(6):499-503. PubMed ID: 22774602
[TBL] [Abstract][Full Text] [Related]
15. Zinc and cadmium concentration in prostatic carcinoma of different histological grading in comparison to normal prostate tissue and adenofibromyomatosis (BPH).
Feustel A; Wennrich R; Steiniger D; Klauss P
Urol Res; 1982; 10(6):301-3. PubMed ID: 6186062
[TBL] [Abstract][Full Text] [Related]
16. Activation of the Erk/MAPK signaling pathway is a driver for cadmium induced prostate cancer.
Dasgupta P; Kulkarni P; Bhat NS; Majid S; Shiina M; Shahryari V; Yamamura S; Tanaka Y; Gupta RK; Dahiya R; Hashimoto Y
Toxicol Appl Pharmacol; 2020 Aug; 401():115102. PubMed ID: 32512071
[TBL] [Abstract][Full Text] [Related]
17. Differential growth factor responses of epithelial cell cultures derived from normal human prostate, benign prostatic hyperplasia, and primary prostate carcinoma.
Chopra DP; Grignon DJ; Joiakim A; Mathieu PA; Mohamed A; Sakr WA; Powell IJ; Sarkar FH
J Cell Physiol; 1996 Nov; 169(2):269-80. PubMed ID: 8908194
[TBL] [Abstract][Full Text] [Related]
18. Chronic toxic and carcinogenic effects of oral cadmium in the Noble (NBL/Cr) rat: induction of neoplastic and proliferative lesions of the adrenal, kidney, prostate, and testes.
Waalkes MP; Anver MR; Diwan BA
J Toxicol Environ Health A; 1999 Oct; 58(4):199-214. PubMed ID: 10591488
[TBL] [Abstract][Full Text] [Related]
19. Different perforin expression in peripheral blood and prostate tissue in patients with benign prostatic hyperplasia and prostate cancer.
Tokmadžić VS; Tomaš MI; Sotošek S; Laškarin G; Dominović M; Tulić V; Dorđević G; Sustić A; Mrakovčić-Šutić I
Scand J Immunol; 2011 Oct; 74(4):368-76. PubMed ID: 21535078
[TBL] [Abstract][Full Text] [Related]
20. Expression of NGF, GDNF and MMP-9 in prostate carcinoma.
Baspinar S; Bircan S; Ciris M; Karahan N; Bozkurt KK
Pathol Res Pract; 2017 May; 213(5):483-489. PubMed ID: 28237042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
